Small-molecule PIK-93 modulates the tumor microenvironment to improve immune checkpoint blockade response
Sign Up to like & getrecommendations! Published in 2023 at "Science Advances"
DOI: 10.1126/sciadv.ade9944
Abstract: Immune checkpoint inhibitors (ICIs) targeting PD-L1 immunotherapy are state-of-the-art treatments for advanced non–small cell lung cancer (NSCLC). However, the treatment response of certain patients with NSCLC is unsatisfactory because of an unfavorable tumor microenvironment (TME)… read more here.
Keywords: small molecule; molecule pik; immune checkpoint; tumor microenvironment ... See more keywords